Finance

Beta
Lists
KAPA:NYSEAMERICAN
Kairos Pharma Ltd
$0.49
-6.26%
(-0.033) 1D
$0.51
+3.12% (+0.015)
After hours
Closed: May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KAPA...
Open
$0.52
High
$0.52
Low
$0.48
Mkt. cap
10.52M
Avg. vol.
163.51K
Volume
126.85K
52-wk high
$2.11
52-wk low
$0.40
EPS
-$0.30
Shares outstanding
21.41M
No. of employees
3
Open
$0.52
High
$0.52
Low
$0.48
Mkt. cap
10.52M
Avg. vol.
163.51K
Volume
126.85K
52-wk high
$2.11
52-wk low
$0.40
EPS
-$0.30
Shares outstanding
21.41M
No. of employees
3
News stories
From sources across the web
About Kairos Pharma Ltd
CEO-
Employees3
Founded2013
HeadquartersLos Angeles, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
496.00K
608.00K
538.00K
684.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
960.00K
827.00K
877.00K
1.01M
Operating expense
1.46M
1.44M
1.42M
1.69M
Total operating expenses
1.46M
1.44M
1.42M
1.69M
Operating income
-1.46M
-1.44M
-1.42M
-1.69M
Other non operating income
-
-
-
-
EBT including unusual items
-1.42M
-1.40M
-1.36M
-1.65M
EBT excluding unusual items
-1.42M
-1.40M
-1.36M
-1.65M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.42M
-1.40M
-1.36M
-1.65M
Net profit margin
-
-
-
-
Earnings per share
-0.08
-0.07
-0.07
-0.08
Interest and investment income
34.00K
37.00K
50.00K
36.00K
Interest expense
-
-
-
-
Net interest expenses
34.00K
37.00K
50.00K
36.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.42M
-1.40M
-1.38M
-1.65M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more